Analysis of commercially available snake antivenoms reveals high contents of endotoxins in some products

As injectable therapeutics, snake antivenoms must meet specifications for endotoxin content. The Limulus amebocyte lysate (LAL) test was used to evaluate the endotoxin content in several commercially available antivenoms released for clinical use. It was found that some products have endotoxin conce...

Full description

Bibliographic Details

Published in:	Toxicon: X
Main Authors:	Gabriela Solano, Stuart Ainsworth, Adriana Sánchez, Mauren Villalta, Paola Sánchez, Gina Durán, José María Gutiérrez, Guillermo León
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Subjects:	Endotoxin Limulus amebocyte lysate test Snake antivenom Pyrogen
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590171024000043